We have confirmed the higher expression of RanBP3 in BCR-ABL+ cells compared with BCR-ABL- cells (Figures 1A–F), so it is necessary to figure out the relation of RanBP3 and BCR-ABL activity in CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.